Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Vaccine Effectiveness Against Influenza A(H3N2)–Associated Hospitalized Illness: United States, 2022

Clinical Infectious Diseases(2022)10.1093/cid/ciac869Source: DataRank Database

Vaccine Effectiveness Against Influenza A(H3N2)–Associated Hospitalized Illness: United States, 2022 is a research paper published in Clinical Infectious Diseases (2022). On theSindex it has a DataRank of 0. It has been cited 23 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access23 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)OA: hybridTopics (49)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (31)

Manish M. Patel ORCID,Nathaniel M. Lewis ORCID,Katherine Adams ORCID,Manjusha Gaglani ORCID,Jay S. Steingrub ORCID

Live enrichment

PubMed:36327388 PMC:PMC10226741

Clinical and Translational Science Award

Grant: UL1 TR002243

NIGMS NIH HHS

Grant: K23 GM129661

NIAID NIH HHS

Grant: K24 AI148459

National Institutes of Health

Grant: 5UL1TR002243-05

Vanderbilt Institute for Clinical and Translational Research (VICTR)

National Institutes of Health

Grant: 1K23AI137321-01A1

Longitudinal Analysis of the Fecal Microbiome and Resistome of Patients with Multidrug-Resistant Urinary Tract Infections and Predictors of Recurrence

NIH

National Center for Advancing Translational Sciences

Centers for Disease Control and Prevention

hybridLicense: public-domain

publisherhttps://academic.oup.com/cid/article-pdf/76/6/1030/49587476/ciac869.pdf

publisherhttps://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciac869/47465669/ciac869.pdf

publisherhttps://academic.oup.com/cid/article-pdf/76/6/1030/50482722/ciac869.pdf

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10226741/pdf/ciac869.pdf

https://doi.org/10.1093/cid/ciac869

Fields of Study

03 medical and health sciences0303 health sciences

MeSH Terms

HumansInfluenza VaccinesHospitalizationSeasonsAdolescentAdultAgedMiddle AgedUnited StatesFemaleMaleInfluenza, HumanInfluenza A Virus, H3N2 SubtypeYoung AdultSARS-CoV-2Vaccine Efficacy

Keywords

InfluenzaVaccine EffectivenessAntigenic DriftSars-cov-2AdultMaleAdolescent610Vaccine EfficacyYoung AdultInfluenza, HumanInfluenza A VirusMedicine and Health SciencesHumansPandemicsAgedInfluenza A Virus, H3N2 SubtypeVaccinationICTS (Institute of Clinical and Translational Sciences)COVID-19Middle AgedUnited StatesHospitalizationInfluenza B virusInfluenza VaccinesCase-Control StudiesH3N2 SubtypePulmonary/Critical Care MedicineFemaleSeasonsHuman

Sustainable Development Goals

SDG 3: 3. Good health

Vaccine Effectiveness Against Influenza A(H3N2)–Associated Hospitalized Illness: United States, 2022

FAIR Checklist

Authors (31)

Funding (8 grants)

Open Access

Topics

Annotations (Europe PMC)